Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002476 |
---|---|
Receipt number | R000002872 |
Scientific Title | A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2) |
Date of disclosure of the study information | 2009/09/10 |
Last modified on | 2018/09/20 08:20:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/09/10 14:31:36 | ||
2 | Update | 2012/06/08 10:49:10 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
3 | Update | 2012/08/29 12:59:25 | Email |
|
4 | Update | 2013/09/01 17:37:25 | Email Address Address |
|
5 | Update | 2014/02/24 10:42:39 | Results Results |
|
6 | Update | 2014/07/25 11:55:04 | Results |
|
7 | Update | 2015/07/02 21:46:52 | Interventions/Control_1 Interventions/Control_1 |
|
8 | Update | 2015/07/02 21:48:27 | Results |
|
9 | Update | 2015/11/18 09:46:46 | Recruitment status Results Other related information |
|
10 | Update | 2016/04/04 16:04:25 | Name of primary person or sponsor Organization |
|
11 | Update | 2018/09/20 08:20:50 | Recruitment status |